Gene therapy in rodent amygdala against fear disorders

Expert Opinion on Biological Therapy

Volumn 10, Issue 9, 2010, Pages 1289-1303

  Mitra, Rupshi ^a   Sapolsky, Robert M ^a  

^a STANFORD UNIVERSITY   (United States)

Author keywords

Amygdala; Anxiety; Fear; Gene therapy; Hypertrophy; Rats; Viral vector

Indexed keywords

AMPA RECEPTOR; BRAIN DERIVED NEUROTROPHIC FACTOR; CORTICOTROPIN; CORTICOTROPIN RELEASING FACTOR; ESTROGEN RECEPTOR; GLUCOCORTICOID RECEPTOR; GLUTAMATE RECEPTOR 1; LENTIVIRUS VECTOR; MINERALOCORTICOID RECEPTOR; N METHYL DEXTRO ASPARTIC ACID RECEPTOR; PARVOVIRUS VECTOR; STRESS HORMONE; VIRUS VECTOR;

AMYGDALOID NUCLEUS; ANXIETY DISORDER; CELL FUNCTION; DENDRITE; EMOTIONAL DISORDER; FEAR; GENE THERAPY; HERPES SIMPLEX VIRUS; HUMAN; NONHUMAN; REVIEW; RODENT; SIGNAL TRANSDUCTION;

AMYGDALA; ANIMALS; ANXIETY DISORDERS; BEHAVIOR, ANIMAL; DISEASE MODELS, ANIMAL; FEAR; GENE THERAPY; MICE; RATS;

RATTUS; RODENTIA;

EID: 77955539289     PISSN: 14712598     EISSN: None     Source Type: Journal    
DOI: 10.1517/14712598.2010.509341     Document Type: Review

References (130)

1. Lang PJ, Davis M. Emotion, motivation, and the brain: reflex foundations in animal and human research. Prog Brain Res 2006;156:3-29
2. LeDoux J. The amygdala. Curr Biol 2007;17:R868-74
3. Maren S. Synaptic mechanisms of associative memory in the amygdala. Neuron 2005;47:783-786
4. Phelps EA, LeDoux JE. Contributions of the amygdala to emotion processing: from animal models to human behavior. Neuron 2005;48:175-187
5. Sigurdsson T, Doyere V, Cain CK, LeDoux JE. Long-term potentiation in the amygdala: a cellular mechanism of fear learning and memory. Neuropharmacology 2007;52:215-227
6. Walker DL, Davis M. The role of amygdala glutamate receptors in fear learning, fear-potentiated startle, and extinction. Pharmacol Biochem Behav 2002;71:379-392 (Pubitemid 34117707)
7. Canteras NS. The medial hypothalamic defensive system: hodological organization and functional implications. Pharmacol Biochem Behav 2002;71:481-491
8. Dielenberg RA, Hunt GE, McGregor IS. When a rat smells a cat: the distribution of Fos immunoreactivity in rat brain following exposure to a predatory odor. Neuroscience 2001;104:1085-1097
9. Adamec RE, Burton P, Shallow T, Budgell J. Unilateral block of NMDA receptors in the amygdala prevents predator stress-induced lasting increases in anxiety-like behavior and unconditioned startle-effective hemisphere depends on the behavior. Physiol Behav 1999;65:739-751
10. Sajdyk TJ, Shekhar A. Excitatory amino acid receptors in the basolateral amygdala regulate anxiety responses in the social interaction test. Brain Res 1997;764:262-264
11. Sajdyk TJ, Shekhar A. Excitatory amino acid receptor antagonists block the cardiovascular and anxiety responses elicited by gamma-aminobutyric acidA receptor blockade in the basolateral amygdala of rats. J Pharmacol Exp Ther 1997;283:969-977
12. Mitra R, Adamec R, Sapolsky R. Resilience against predator stress and dendritic morphology of amygdala neurons. Behav Brain Res 2009;205:535-543
13. Mitra R, Jadhav S, McEwen BS, et al. Stress duration modulates the spatiotemporal patterns of spine formation in the basolateral amygdala. Proc Natl Acad Sci USA 2005;102:9371-9376
14. Mitra R, Sapolsky RM. Acute corticosterone treatment is sufficient to induce anxiety and amygdaloid dendritic hypertrophy. Proc Natl Acad Sci USA 2008;105:5573-5578
15. Rainnie DG, Bergeron R, Sajdyk TJ, et al. Corticotrophin releasing factor-induced synaptic plasticity in the amygdala translates stress into emotional disorders. J Neurosci 2004;24:3471-3479
16. Dunn JD, Whitener J. Plasma corticosterone responses to electrical stimulation of the amygdaloid complex: cytoarchitectural specificity. Neuroendocrinology 1986;42:211-217
17. Gabr RW, Birkle DL, Azzaro AJ. Stimulation of the amygdala by glutamate facilitates corticotropin-releasing factor release from the median eminence and activation of the hypothalamic-pituitary-adrenal axis in stressed rats. Neuroendocrinology 1995;62:333-339
18. Herman JP, Cullinan WE. Neurocircuitry of stress: central control of the hypothalamo-pituitary-adrenocortical axis. Trends Neurosci 1997;20:78-84
19. Shepard JD, Barron KW, Myers DA. Stereotaxic localization of corticosterone to the amygdala enhances hypothalamo-pituitary-adrenal responses to behavioral stress. Brain Res 2003;963:203-213
20. de Kloet ER. Adrenal steroids as modulators of nerve cell function. J Steroid Biochem 1984;20:175-181
21. Kessler RC, Chiu WT, Demler O, et al. Prevalence, severity, and comorbidity of 12-month DSM-IV disorders in the National Comorbidity Survey Replication. Arch Gen Psychiatry 2005;62:617-627 (Pubitemid 40973437)
22. NIMH. The numbers count: mental disorders in America. NIMH, Bethesda, MD, USA; 2008
23. Kessler RC, Heeringa S, Lakoma MD, et al. Individual and societal effects of mental disorders on earnings in the United States: results from the national comorbidity survey replication. Am J Psychiatry 2008;165:703-711
24. Arch JJ, Craske MG. First-line treatment: a critical appraisal of cognitive behavioral therapy developments and alternatives. Psychiatr Clin North Am 2009;32:525-547
25. Davidson JR. First-line pharmacotherapy approaches for generalized anxiety disorder. J Clin Psychiatry 2009;70(Suppl 2):25-31
26. Hutchinson MA, Smith PF, Darlington CL. The behavioural and neuronal effects of the chronic administration of benzodiazepine anxiolytic and hypnotic drugs. Prog Neurobiol 1996;49:73-97
27. Nutt DJ, Malizia AL. New insights into the role of the GABAA-benzodiazepine receptor in psychiatric disorder. Br J Psychiatry 2001;179:390-396
28. Brunello N, Blier P, Judd LL, et al. Noradrenaline in mood and anxiety disorders: basic and clinical studies. Int Clin Psychopharmacol 2003;18:191-202
29. DellOsso B, Buoli M, Baldwin DS, Altamura AC. Serotonin norepinephrine reuptake inhibitors (SNRIs) in anxiety disorders: a comprehensive review of their clinical efficacy. Hum Psychopharmacol 2010;25:17-29
30. Masand PS, Gupta S. Selective serotonin-reuptake inhibitors: an update. Harv Rev Psychiatry 1999;7:69-84
31. Millan MJ. The neurobiology and control of anxious states. Prog Neurobiol 2003;70:83-244
32. Nutt DJ, Forshall S, Bell C, et al. Mechanisms of action of selective serotonin reuptake inhibitors in the treatment of psychiatric disorders. Eur Neuropsychopharmacol 1999;9(Suppl 3):S81-6
33. Silverstone PH. Qualitative review of SNRIs in anxiety. J Clin Psychiatry 2004;65(Suppl 17):19-28
34. Zohar J, Westenberg HG. Anxiety disorders: a review of tricyclic antidepressants and selective serotonin reuptake inhibitors. Acta Psychiatr Scand Suppl 2000;403:39-49
35. Mettenleiter TC, Klupp BG, Granzow H. Herpesvirus assembly: a tale of two membranes. Curr Opin Microbiol 2006;9:423-429
36. Berges BK, Wolfe JH, Fraser NW. Transduction of brain by herpes simplex virus vectors. Mol Ther 2007;15:20-29
37. Carlezon WA Jr, Nestler EJ, Neve RL. Herpes simplex virus-mediated gene transfer as a tool for neuropsychiatric research. Crit Rev Neurobiol 2000;14:47-67
38. Glorioso JC, Fink DJ. Herpes vector-mediated gene transfer in treatment of diseases of the nervous system. Annu Rev Microbiol 2004;58:253-271
39. Maguire-Zeiss KA, Bowers WJ, Federoff HJ. HSV vector-mediated gene delivery to the central nervous system. Curr Opin Mol Ther 2001;3:482-490
40. Yenari MA, Dumas TC, Sapolsky RM, Steinberg GK. Gene therapy for treatment of cerebral ischemia using defective herpes simplex viral vectors. Ann N Y Acad Sci 2001;939:340-357
41. Jakobsson J, Lundberg C. Lentiviral vectors for use in the central nervous system. Mol Ther 2006;13:484-493
42. Kafri T. Lentivirus vectors: difficulties and hopes before clinical trials. Curr Opin Mol Ther 2001;3:316-326
43. Lundberg C, Bjorklund T, Carlsson T, et al. Applications of lentiviral vectors for biology and gene therapy of neurological disorders. Curr Gene Ther 2008;8:461-473
44. Nanou A, Azzouz M. Gene therapy for neurodegenerative diseases based on lentiviral vectors. Prog Brain Res 2009;175:187-200
45. Danos O. AAV vectors for RNA-based modulation of gene expression. Gene Ther 2008;15:864-869
46. Grieger JC, Samulski RJ. Adeno-associated virus as a gene therapy vector: vector development, production and clinical applications. Adv Biochem Eng Biotechnol 2005;99:119-145
47. Hester ME, Foust KD, Kaspar RW, Kaspar BK. AAV as a gene transfer vector for the treatment of neurological disorders: novel treatment thoughts for ALS. Curr Gene Ther 2009;9:428-433
48. Noe F, Frasca A, Balducci C, et al. Neuropeptide Y overexpression using recombinant adeno-associated viral vectors. Neurotherapeutics 2009;6:300-306
49. Tenenbaum L, Chtarto A, Lehtonen E, et al. Recombinant AAV-mediated gene delivery to the central nervous system. J Gene Med 2004;6(Suppl 1):S212-22
50. Allocca M, Doria M, Petrillo M, et al. Serotype-dependent packaging of large genes in adeno-associated viral vectors results in effective gene delivery in mice. J Clin Invest 2008;118:1955-1964
51. Grieger JC, Samulski RJ. Packaging capacity of adeno-associated virus serotypes: impact of larger genomes on infectivity and postentry steps. J Virol 2005;79:9933-9944
52. Tenenbaum L, Lehtonen E, Monahan PE. Evaluation of risks related to the use of adeno-associated virus-based vectors. Curr Gene Ther 2003;3:545-565
53. Blair HT, Schafe GE, Bauer EP, et al. Synaptic plasticity in the lateral amygdala: a cellular hypothesis of fear conditioning. Learn Mem 2001;8:229-242
54. Rodrigues SM, Schafe GE, LeDoux JE. Molecular mechanisms underlying emotional learning and memory in the lateral amygdala. Neuron 2004;44:75-91
55. Rumpel S, LeDoux J, Zador A, Malinow R. Postsynaptic receptor trafficking underlying a form of associative learning. Science 2005;308:83-88
56. Mineka S, Ohman A. Phobias and preparedness: the selective, automatic, and encapsulated nature of fear. Biol Psychiatry 2002;52:927-937
57. Ohman A, Mineka S. Fears, phobias, and preparedness: toward an evolved module of fear and fear learning. Psychol Rev 2001;108:483-522
58. Ost LG, Hugdahl K. Acquisition of blood and dental phobia and anxiety response patterns in clinical patients. Behav Res Ther 1985;23:27-34
59. Rodrigues SM, Schafe GE, LeDoux JE. Intra-amygdala blockade of the NR2B subunit of the NMDA receptor disrupts the acquisition but not the expression of fear conditioning. J Neurosci 2001;21:6889-6896
60. Dumas TC, Sapolsky RM. Gene therapy against neurological insults: sparing neurons versus sparing function. Trends Neurosci 2001;24:695-700
61. Harvey S, Phillips JG, Rees A, Hall TR. Stress and adrenal function. J Exp Zool 1984;232:633-645
62. Lightman SL, Windle RJ, Ma XM, et al. Hypothalamic-pituitary-adrenal function. Arch Physiol Biochem 2002;110:90-93
63. Sapolsky RM, Meaney MJ. Maturation of the adrenocortical stress response: neuroendocrine control mechanisms and the stress hyporesponsive period. Brain Res 1986;396:64-76
64. Gray TS, Bingaman EW. The amygdala: corticotropin-releasing factor, steroids, and stress. Crit Rev Neurobiol 1996;10:155-168
65. Kolber BJ, Muglia LJ. Defining brain region-specific glucocorticoid action during stress by conditional gene disruption in mice. Brain Res 2009;1293:85-90
66. Pryce CR. Postnatal ontogeny of expression of the corticosteroid receptor genes in mammalian brains: inter-species and intra-species differences. Brain Res Rev 2008;57:596-605
67. Hayashi R, Wada H, Ito K, Adcock IM. Effects of glucocorticoids on gene transcription. Eur J Pharmacol 2004;500:51-62
68. Heitzer MD, Wolf IM, Sanchez ER, et al. Glucocorticoid receptor physiology. Rev Endocr Metab Disord 2007;8:321-330
69. Revollo JR, Cidlowski JA. Mechanisms generating diversity in glucocorticoid receptor signaling. Ann N Y Acad Sci 2009;1179:167-178
70. Cui H, Sakamoto H, Higashi S, Kawata M. Effects of single-prolonged stress on neurons and their afferent inputs in the amygdala. Neuroscience 2008;152:703-712
71. Myers B, Greenwood-Van Meerveld B. Corticosteroid receptor-mediated mechanisms in the amygdala regulate anxiety and colonic sensitivity. Am J Physiol Gastrointest Liver Physiol 2007;292:G1622-9
72. Venkova K, Foreman RD, Greenwood-Van Meerveld B. Mineralocorticoid and glucocorticoid receptors in the amygdala regulate distinct responses to colorectal distension. Neuropharmacology 2009;56:514-521
73. de Kloet ER, Oitzl MS, Joels M. Functional implications of brain corticosteroid receptor diversity. Cell Mol Neurobiol 1993;13:433-455
74. Nair SM, Werkman TR, Craig J, et al. Corticosteroid regulation of ion channel conductances and mRNA levels in individual hippocampal CA1 neurons. J Neurosci 1998;18:2685-2696
75. de Kloet ER, Rots NY, van den Berg DT, Oitzl MS. Brain mineralocorticoid receptor function. Ann N Y Acad Sci 1994;746:8-20; discussion 20-1, 64-67
76. Lai M, Horsburgh K, Bae SE, et al. Forebrain mineralocorticoid receptor overexpression enhances memory, reduces anxiety and attenuates neuronal loss in cerebral ischaemia. Eur J Neurosci 2007;25:1832-1842
77. Yau JL, Noble J, Seckl JR. Continuous blockade of brain mineralocorticoid receptors impairs spatial learning in rats. Neurosci Lett 1999;277:45-48
78. de Kloet ER. Stress in the brain. Eur J Pharmacol 2000;405:187-98
79. de Kloet ER. Hormones and the stressed brain. Ann N Y Acad Sci 2004;1018:1-15
80. Oitzl MS, Champagne DL, van der Veen R, de Kloet ER. Brain development under stress: hypotheses of glucocorticoid actions revisited. Neurosci Biobehav Rev 2010;34:853-866
81. Mitra R, Ferguson D, Sapolsky RM. Mineralocorticoid receptor overexpression in basolateral amygdala reduces corticosterone secretion and anxiety. Biol Psychiatry 2009;66:686-690
82. Rodrigues SM, Sapolsky RM. Disruption of fear memory through dual-hormone gene therapy. Biol Psychiatry 2009;65:441-444
83. Daniel JM. Effects of oestrogen on cognition: what have we learned from basic research? J Neuroendocrinol 2006;18:787-795
84. Garcia-Segura LM, Azcoitia I, DonCarlos LL. Neuroprotection by estradiol. Prog Neurobiol 2001;63:29-60
85. Woolley CS. Acute effects of estrogen on neuronal physiology. Annu Rev Pharmacol Toxicol 2007;47:657-680
86. Kaufer D, Ogle WO, Pincus ZS, et al. Restructuring the neuronal stress response with anti-glucocorticoid gene delivery. Nat Neurosci 2004;7:947-953
87. Rall W. Branching dendritic trees and motoneuron membrane resistivity. Exp Neurol 1959;1:491-527
88. Vyas A, Mitra R, Shankaranarayana Rao BS, Chattarji S. Chronic stress induces contrasting patterns of dendritic remodeling in hippocampal and amygdaloid neurons. J Neurosci 2002;22:6810-6818
89. Vaillant AR, Zanassi P, Walsh GS, et al. Signaling mechanisms underlying reversible, activity-dependent dendrite formation. Neuron 2002;34:985-998
90. Wilson MT, Kisaalita WS, Keith CH. Glutamate-induced changes in the pattern of hippocampal dendrite outgrowth: a role for calcium-dependent pathways and the microtubule cytoskeleton. J Neurobiol 2000;43:159-172
91. Rajan I, Witte S, Cline HT. NMDA receptor activity stabilizes presynaptic retinotectal axons and postsynaptic optic tectal cell dendrites in vivo. J Neurobiol 1999;38:357-368
92. Inglis FM, Crockett R, Korada S, et al. The AMPA receptor subunit GluR1 regulates dendritic architecture of motor neurons. J Neurosci 2002;22:8042-8051
93. Joels M. Stress, the hippocampus, and epilepsy. Epilepsia 2009;50:586-597
94. Mitra R, Ferguson D, Sapolsky RM. SK2 potassium channel overexpression in basolateral amygdala reduces anxiety, stress-induced corticosterone secretion and dendritic arborization. Mol Psychiatry 2009;14:847-55, 827
95. Madison DV, Nicoll RA. Control of the repetitive discharge of rat CA 1 pyramidal neurones in vitro. J Physiol 1984;354:319-331
96. Lu Y, Christian K, Lu B. BDNF: a key regulator for protein synthesis-dependent LTP and long-term memory? Neurobiol Learn Mem 2008;89:312-323
97. Waterhouse EG, Xu B. New insights into the role of brain-derived neurotrophic factor in synaptic plasticity. Mol Cell Neurosci 2009;42:81-89
98. Bramham CR, Messaoudi E. BDNF function in adult synaptic plasticity: the synaptic consolidation hypothesis. Prog Neurobiol 2005;76:99-125
99. Pezet S, Malcangio M. Brain-derived neurotrophic factor as a drug target for CNS disorders. Expert Opin Ther Targets 2004;8:391-399
100. Yamada K, Nabeshima T. Brain-derived neurotrophic factor/TrkB signaling in memory processes. J Pharmacol Sci 2003;91:267-270
101. Rattiner LM, Davis M, French CT, Ressler KJ. Brain-derived neurotrophic factor and tyrosine kinase receptor B involvement in amygdala-dependent fear conditioning. J Neurosci 2004;24:4796-4806
102. Wallace TL, Stellitano KE, Neve RL, Duman RS. Effects of cyclic adenosine monophosphate response element binding protein overexpression in the basolateral amygdala on behavioral models of depression and anxiety. Biol Psychiatry 2004;56:151-160
103. Kang W, Wilson SP, Wilson MA. Overexpression of proenkephalin in the amygdala potentiates the anxiolytic effects of benzodiazepines. Neuropsychopharmacology 2000;22:77-88
104. Lang PJ, Davis M, Ohman A. Fear and anxiety: animal models and human cognitive psychophysiology. J Affect Disord 2000;61:137-159
105. LeDoux JE. Emotion circuits in the brain. Annu Rev Neurosci 2000;23:155-184
106. Sapolsky RM. Neuroprotective gene therapy against acute neurological insults. Nat Rev Neurosci 2003;4:61-69
107. Sapolsky RM, Steinberg GK. Gene therapy using viral vectors for acute neurologic insults. Neurology 1999;53:1922-1931
108. Capsoni S, Covaceuszach S, Ugolini G, et al. Delivery of NGF to the brain: intranasal versus ocular administration in anti-NGF transgenic mice. J Alzheimers Dis 2009;16:371-388
109. De Rosa R, Garcia AA, Braschi C, et al. Intranasal administration of nerve growth factor (NGF) rescues recognition memory deficits in AD11 anti-NGF transgenic mice. Proc Natl Acad Sci USA 2005;102:3811-3816
110. Sapolsky RM. Altering behavior with gene transfer in the limbic system. Physiol Behav 2003;79:479-486
111. Cuchet D, Potel C, Thomas J, Epstein AL. HSV-1 amplicon vectors: a promising and versatile tool for gene delivery. Expert Opin Biol Ther 2007;7:975-995
112. Chinen J, Puck JM. Successes and risks of gene therapy in primary immunodeficiencies. J Allergy Clin Immunol 2004;113:595-603; quiz 604
113. Lehrman S. Virus treatment questioned after gene therapy death. Nature 1999;401:517-518
114. Marshall E. Gene therapy death prompts review of adenovirus vector. Science 1999;286:2244-2245
115. Bilbao G, Feng M, Rancourt C, et al. Adenoviral/retroviral vector chimeras: a novel strategy to achieve high-efficiency stable transduction in vivo. FASEB J 1997;11:624-634 (Pubitemid 27318280)
116. Epstein AL, Manservigi R. Herpesvirus/retrovirus chimeric vectors. Curr Gene Ther 2004;4:409-416
117. Glauser DL, Ackermann M, Saydam O, Fraefel C. Chimeric herpes simplex virus/adeno-associated virus amplicon vectors. Curr Gene Ther 2006;6:315-324
118. Reynolds PN, Feng M, Curiel DT. Chimeric viral vectors-the best of both worlds? Mol Med Today 1999;5:25-31
119. Haviv YS, Curiel DT. Conditional gene targeting for cancer gene therapy. Adv Drug Deliv Rev 2001;53:135-154
120. Ho DY, McLaughlin JR, Sapolsky RM. Inducible gene expression from defective herpes simplex virus vectors using the tetracycline-responsive promoter system. Brain Res Mol Brain Res 1996;41:200-209
121. Ozawa CR, Ho JJ, Tsai DJ, et al. Neuroprotective potential of a viral vector system induced by a neurological insult. Proc Natl Acad Sci USA 2000;97:9270-9275
122. Su H, Kan YW. Adeno-associated viral vector-delivered hypoxia-inducible gene expression in ischemic hearts. Methods Mol Biol 2007;366:331-342
123. Hommel JD, Sears RM, Georgescu D, et al. Local gene knockdown in the brain using viral-mediated RNA interference. Nat Med 2003;9:1539-1544
124. Aroniadou-Anderjaska V, Qashu F, Braga MF. Mechanisms regulating GABAergic inhibitory transmission in the basolateral amygdala: implications for epilepsy and anxiety disorders. Amino Acids 2007;32:305-315
125. Benes FM, Berretta S. GABAergic interneurons: implications for understanding schizophrenia and bipolar disorder. Neuropsychopharmacology 2001;25:1-27
126. Rainnie DG. Inhibitory and excitatory circuitries in amygdala nuclei: a synopsis of session II. Ann N Y Acad Sci 2003;985:59-66
127. Feder A, Nestler EJ, Charney DS. Psychobiology and molecular genetics of resilience. Nat Rev Neurosci 2009;10:446-457
128. Alleva E, Francia N. Psychiatric vulnerability: suggestions from animal models and role of neurotrophins. Neurosci Biobehav Rev 2009;33:525-536
129. Lyons DM, Parker KJ. Stress inoculation-induced indications of resilience in monkeys. J Trauma Stress 2007;20:423-433
130. Southwick SM, Vythilingam M, Charney DS. The psychobiology of depression and resilience to stress: implications for prevention and treatment. Annu Rev Clin Psychol 2005;1:255-291